HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rebecca Amariglio Selected Research

Therapeutics

1/2016Tau positron emission tomographic imaging in aging and early Alzheimer disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rebecca Amariglio Research Topics

Disease

10Cognitive Dysfunction
11/2023 - 01/2013
10Alzheimer Disease (Alzheimer's Disease)
11/2023 - 01/2013
3Dementia (Dementias)
01/2022 - 01/2016
2Atrophy
11/2023 - 12/2021
2Disease Progression
12/2021 - 01/2016
2Tauopathies
10/2016 - 01/2016
1Agnosia (Visual Agnosia)
01/2017

Drug/Important Bio-Agent (IBA)

7Amyloid (Amyloid Fibrils)IBA
12/2023 - 01/2016
7Biomarkers (Surrogate Marker)IBA
11/2023 - 01/2013
1Amyloid beta-PeptidesIBA
11/2023
1Indicators and Reagents (Reagents)IBA
01/2022
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
01/2016
12- (4'- (methylamino)phenyl)- 6- hydroxybenzothiazole (Pittsburgh compound B)IBA
01/2016

Therapy/Procedure

2Secondary Prevention
09/2017 - 11/2016
1Therapeutics
01/2016